Skip to main content

Table 7 Comparison between case and control groups as regards creatinine (mg/dL)

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

Creatinine

Group A

Group B

A/B^

Before

Median (IQR)

1.10

(0.83–1.30)

1.15

(0.93–1.30)

0.594

Range

0.60–2.30

0.80–1.80

After

Median (IQR)

1.00

(0.73–1.28)

1.30

(1.20–1.50)

0.003*

Range

0.20–2.00

0.80–2.50

Difference

Median (IQR)

0.00

(− 0.28–0.10)

0.10

(0.03–0.28)

0.013*

Range

− 2.10–1.00

0.00–1.60

p#

0.505

< 0.001*

 
  1. Negative values indicate reduction
  2. Md median, IQR interquartile range
  3. ^Mann-Whitney test
  4. #Wilcoxon signed rank test
  5. *Significant